v3.26.1
Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Oct. 07, 2025
Oct. 18, 2024
Summary Of Significant Accounting Policies          
Earned and unbilled receivables $ 39.0   $ 30.0    
Maximum outstanding amount of accounts receivable     150.0   $ 450.0
Net cash proceeds under the Receivables Sale program   $ 343.0      
Accounts receivable sold under program, continuing operations   69.0      
Cash proceeds from collection of accounts receivable   209.0      
Proceeds from collection of accounts receivables, continuing operations   42.0      
Losses on sale of accounts receivable 1.5        
Accounts receivable sold under amended program 246.0        
Proceeds from accounts receivable 231.0        
Losses on sale of accounts receivable   0.4      
Uncollected accounts receivable 148.0   134.0    
Accumulated benefit obligation 30.0   31.0    
Acquisition-related charges $ 0.0 16.0      
Products & Healthcare Services          
Summary Of Significant Accounting Policies          
Net cash proceeds under the Receivables Sale program   274.0      
Cash proceeds from collection of accounts receivable   $ 167.0      
Uncollected accounts receivable     $ 0.0    
Products & Healthcare Services | Discontinued Operations, Held-for-sale          
Summary Of Significant Accounting Policies          
Cash consideration       $ 375.0  
Percentage of equity interest retained       5.00%